Eye scan helps predict future disability in early MS

Credibility

Interest

Key Takeaway

A simple eye scan that measures inner retinal layers can help predict who with early relapsing MS is more likely to gain disability over the next few years.

What They Found

Researchers scanned the eyes of 231 people soon after they were diagnosed with relapsing MS and followed them for about five years. They measured two retinal layers: the GCIPL (the layer with nerve cells that connect the eye to the brain) and the pRNFL (the layer of nerve fibers that form the optic nerve). People with thinner GCIPL (less than 77 micrometers) or thinner pRNFL (88 micrometers or less) were more likely to reach a level of disability that affects walking and daily tasks. Other things that raised risk were being older, having more MRI spots in the brain, certain MRI spots near the brainstem/cerebellum, and not fully recovering after the first MS attack. Starting a strong disease-modifying treatment lowered the risk of disability over time.

Who Should Care and Why

People newly diagnosed with relapsing MS should care because an eye scan is quick and painless and can add helpful information about future risk, much like checking the oil in a car gives an early warning about the engine. Caregivers can use this information to plan for support or rehab if their loved one has a higher risk of disability. Neurologists and MS nurses can combine eye scan results with MRI and clinical history to better personalize treatment decisions — for example, choosing stronger treatments sooner when risk looks higher. If your eye scan shows thinner layers, it doesn’t mean disability is certain, but it signals closer monitoring and possibly earlier action. If your scan looks normal, that is reassuring but regular follow-up is still important because MS can change over time.

Important Considerations

This study looked at a specific group of patients (early relapsing MS) and may not apply the same way to people at other stages of MS. An eye scan is only one piece of the puzzle and should be used together with MRI, doctor exams, and symptoms — it does not by itself predict every person’s future. Finally, while thinner retinal layers were linked to higher disability risk, not everyone with thin layers became disabled, so results guide risk but are not a certain prediction.

AI-generated summary — for informational purposes only, not medical advice

Categories:

MS Diagnostics MS Progression Early Research

Article Topics:

biomarkerdisabilitymultiple sclerosisoptical coherence tomographypredictorretina

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like European journal of neurology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News